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Abstract Concentrations in serum were determined for
18 fatty acids (FAs) and 21 lipoprotein main and subclasses
by chromatographic analyses and the average size was
calculated for very low density (VLDL), low density
(LDL) and high density (HDL) particles. 283 ethnic Nor-
wegian children and adults from the rural Fjord region of
Western Norway were compared with the objectives to
reveal patterns and gender differences during the devel-
opment from prepuberty to adulthood and during aging in
adults. Both genders showed a large increase in eicos-
apentaenoic acid (EPA) and docosahexaenoic acid (DHA)
from child to adult. Males, but not females, show a sig-
nificant increase in most C16–C18 FAs from prepuberty to
adulthood. These changes in males correlate to a pattern of
increased concentrations of triglycerides, VLDL and LDL
particles, especially the atherogenic subclasses of small and
very small LDL particles. Furthermore, concentrations of
medium, large and very large HDL particles decrease,
while concentration of very small HDL particles increase
leading to reduced average size of HDL particles. Females
only showed significant increase in concentrations of small
and very small LDL particles, very small HDL particles
and apolipoprotein B. While EPA and DHA continued to
increase during aging in women, no validated model for
connecting age to FA profile was obtained for men.
Women showed significant increase in concentrations of all
subclasses of LDL particles during aging, while men
exhibited a more complex pattern with increase also in
apolipoprotein A1 and HDL particles.
Keywords Human serum  Lipoprotein subclasses  Fatty
acids (FAs)  Docosahexaenoic acid (DHA) 
Eicosapentaenoic acid (EPA)  Aging
1 Introduction
Following the work of Dyerberg et al. (1978) and Kagawa
et al. (1982), which indicated the protective effect of EPA
on risk of developing cardiovascular diseases (CVDs),
several studies have been performed to assess effects of
FAs on lipoprotein distribution and their impact on CVD
risk. Reviews by Chowdhury et al. (2014) and Michas et al.
(2014) summarize the current opinion of the associations of
individual and groups of FAs to CVD risk. The poly-un-
saturated FAs, especially the marine omega-3 FAs (Kelley
and Adkins 2012; Ninomiya et al. 2013), appear to reduce
CVD risk, while saturated and mono-unsaturated FAs
increase CVD risk. Similarly, certain lipoprotein subclasses
have been shown to be connected to increased CVD risk,
e.g., small LDL particles (Hirayama and Miida 2012).
Lin et al. (2016) used multivariate analysis to reveal
relations between lipoprotein subclasses and FA patterns in
a cohort of healthy Norwegians. A limitation in that study
was that only adults were included. Thus, it was not pos-
sible to investigate changes in lipoprotein and FA patterns
accompanying the evolution from child to grown-up.
However, age effects on FA levels have been studied by
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Rise´ et al. (2013). They observed changes in relative levels
of EPA and DHA in blood from child to adult and to
elderly in both genders. Otsuka et al. (2013, 2015) inde-
pendently found positive correlations between age and
absolute concentrations of EPA and DHA in adults aged
40–79 years. Harris et al. (2013) analyzed red blood cells
of 160,000 patients that were examined for cardiovascular
(CV) risk factors and observed an increase in relative
concentrations of EPA and DHA.
Age-related effects have also been observed for
lipoproteins. Total cholesterol levels as well as HDL and
LDL levels peak around the age 9–10 years for children
and then decrease during adolescence before increasing
again from the age 16–17 (Labarthe et al. 2003; Kaitosaari
et al. 2009; Dai et al. 2009). By the end of puberty the
gender dependent patterns of lipoprotein cholesterol are
evident (Stozicki et al. 1991; Freedman et al. 2001). Less is
known about aging effects on lipoprotein patterns in adults,
but Freedman et al. (2004) observed impact on some
lipoprotein subclasses.
Our objectives with this investigation are to disclose
patterns of change, from the prepubertal cholesterol peak in
children to adulthood, and during aging, with possible
implications for cardiovascular health, hidden in the con-
centration profiles of serum FAs and lipoprotein sub-
classes. Furthermore, to explore gender differences in the
alterations of both FAs and lipoprotein features accompa-
nying the development from child to adult and through the
aging process. Multivariate discriminant (Sjo¨stro¨m et al.
1986; Rajalahti et al. 2010) and regression analyses (Wold
et al. 1984) are used as tools to search for patterns.
2 Materials and methods
2.1 Participants
A cohort of 10 years old healthy ethnic Norwegian chil-
dren, 91 boys and 56 girls, and 136 healthy ethnic Nor-
wegian adults, 69 women (age 40 (mean) ± 11 (sd) and 67
men (age 41 ± 11), were recruited in the rural Fjord region
of Western Norway. Approximately half of the children
and adults were recruited in 2011 (Batch A) and half in
2014 (Batch B). A detailed description of the adult cohort
can be found in Lin et al. (2016).
2.2 Blood sampling
Blood samples were collected between 8 and 10 am after
overnight fasting. Serum was obtained according to the
standardized protocol described in Lin et al. (2016). Serum
was split into 0.5 ml aliquots and stored in cryotubes at
-80 C.
2.3 Measurement of fatty acid profile
The serum samples were prepared and FAs quantified by
use of chromatography as described in Lin et al. (2016).
The samples from both surveys were extracted and ana-
lyzed in random order. The total amounts of FAs in each
serum sample were converted into amounts in lg per g
sample by dividing with the sample weights. The medians
of the 18 FAs for children and adults were calculated for
both genders (Supplementary material 1). This dataset
includes the majority of FAs that are considered biologi-
cally important. Total fatty acid (TFA) concentration and
the ratio of EPA to arachidonic (AA), i.e. EPA/AA, are
also included in supplementary material 1. Systematic
names and abbreviations to common names defined in text
are used. See supplementary material 3 for Chebi Ids.
2.4 Measurement and features calculated
for lipoproteins
Serum lipoproteins were analyzed on an HPLC system at
Skylight Biotech (Akita, Japan) according to the procedure
based on high-performance liquid chromatography (HPLC)
analysis and curve fitting to define lipoprotein subclasses
(Usui et al. 2002; Okazaki et al. 2005). Two pools of
subjects, i.e. normolipidemics and hypertriglyceridemics,
were used to establish 20 lipoprotein subclasses. Within-
day precision (n = 5) for the two pools determined as
coefficient of variation (CV) was 0.2–4.4. The samples
were analyzed in two rounds, one in 2011 and one in 2014.
Replicates of five serum samples analyzed in 2011 (Batch
A) were included in the batch B from 2014 in order to be
able to detect and correct for possible systematic differ-
ences between batches.
Using the procedure described in Lin et al. (2016), the
following lipoprotein features were calculated: Concen-
trations of total cholesterol (Chol), triglyceride (TG),
chylomicrons (CM) ([80 nm), VLDL (30–80 nm), LDL
(16–30 nm) and HDL (8–16 nm) particles. Range of par-
ticle size is provided in parentheses. Furthermore, con-
centrations of 4, 4 and 5 subclasses of VLDL, LDL and
HDL particles, respectively, labeled as VLDL-VL (64, and,
53.6), VLDL-L (44.5). VLDL-M (36.8), VLDL-S (31.3),
LDL-L (28.6), LDL-M (25.5), LDL-S (23.0), LDL-VS
(20.7, 18.6, and, 16.7), HDL-VL (15.0, and, 13.5), HDL-L
(12.1), HDL-M (10.9), HDL-S (9.8) and HDL-VS (8.8,
and, 7.6). The abbreviations VL, L, M, S and VS denote
very large, large, medium, small and very small particles,
respectively. The average particle size, in nm, is provided
in parentheses for each of the 20 subclasses defining the 13
subclasses calculated in this work. Where subclasses are
combined, the average diameter of each of the original
subclasses is provided. In addition, average particle size of
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each of the main lipoprotein classes VLDL, LDL and HDL
was estimated. Note that the subclass VLDL-S is often
labeled as intermediate density lipoprotein (IDL).
Serum apolipoproteins A1 (ApoA1) and B (ApoB) were
measured by turbidimetric immunoassay using commer-
cially available kits (Sekisui Medical co., Ltd, Tokyo,
Japan). The serum samples for the children recruited in the
second round were not analyzed for ApoA1 and ApoB.
Medians for all the lipoprotein features for children and
adults of both genders are provided in supplementary
material 2.
2.5 Removal of systematic batch differences
in the lipoprotein data
As explained above, the lipoprotein analyses were performed
in two rounds by HPLC followed by curve resolution and
calculation of main and subclass concentrations and average
particle size for VLDL, LDL and HDL. The second batch of
samples was analyzed approximately 2 years after the anal-
ysis of the first batch. In order to be able to detect possible
systematic differences between the two batches, five samples
from the first batch (A) were reanalyzed together with the
samples from the second batch (B). The profiles of these five
replicated samples revealed relatively large systematic dif-
ferences in some lipoprotein features between the two bat-
ches. The concentrations of VLDL and its subclass VLDL-L
were higher and its subclass VLDL-S lower in the second
batch. For LDL, the picture was opposite with concentrations
of LDL and its subclasses LDL-L and LDL-M being lower
and LDL-S and LDL-VS being larger in the second batch.
These shifts lead to increased average size of VLDL and
decreased average size of LDL particles in the second batch
compared to the first batch. For each of the lipoprotein fea-
tures showing systematic differences, the batch difference
was calculated for each replicate and the measurements of all
samples in the second batch were adjusted by adding the
median of these differences. This procedure assumes that the
five replicates are representative for the analytical differences
between batches and that the effect is additive. After this
preprocessing, termed median difference correction (MDC),
pairs of replicates coincided in the principal component (PC)
score plots (Jolliffe 1986) on the major PCs confirming that
the systematic difference had been eliminated.
2.6 Data analysis
The hypothesis of equal medians in the FAs and lipopro-
teins for the children and the adults were tested for both
genders using Bonferroni corrected values of the Wil-
coxon-Mann–Whitney (WMW) nonparametric rank sum
test (Wilcoxon 1945; Mann and Whitney 1947). Matlab
R2013b was used for calculation (MathWorks, Natick,
Massachusetts, U.S.A). Furthermore, false discovery rates
(Benjamini and Hochberg 1995) were calculated.
Multivariate data analysis was performed bymeans of the
commercial software Sirius Version 10.0 (Pattern Recog-
nition Systems AS, Bergen, Norway). Prior to multivariate
analysis, all variables were centered and standardized to unit
variance. Preprocessing to unit variance was done due to
large differences in variance between variables. Partial least
squares discriminant analysis (PLS-DA) (Sjo¨stro¨m et al.
1986) was used to reveal discriminating features in FA and
lipoprotein patterns between children and adults for both
genders. The FAs (Supplementary material 1) and lipopro-
tein features (Supplementary material 2) were modelled
separately, thus giving rise to four PLS-DA models. Repe-
ated double cross validation (RDCV) (Westerhuis et al.
2008) was used for optimizing the predictive performance of
all models. 100 repetitions were performed with 10 % of the
samples in outer loop and seven partitions in the inner loop.
Mean and standard deviations for RMSEP and Q2Y were
calculated for each PLS component and the number of PLS
components were determined when the value of Q2Y minus
two standard deviation exceeded the previous Q2Y. All
PLS-DA models were further validated by a randomization
test whereby elements in the y-vector were exchanged and
the Q2Y from the true model was compared with the dis-
tributions from 1000 permutations. A p-value was calculated
from the number of permuted models with Q2Y exceeding
Q2Y of the true model. Also for this test, 10 % of the
samples were randomly kept in outer loop until all samples
had been kept out once for each permutation. Percent correct
classification rate (%CCR) was finally calculated as an
additional performance test of the discriminatory ability of
the PLS-DA models. Also for this calculation, prediction
was performed by keeping out 10 % of the samples in the
outer loop. Table 1 summarizes the performance measures
for each model.
For each validated PLS model, a single predictive com-
ponent was calculated by means of target projection (TP)
(Kvalheim and Karstang 1989; Rajalahti and Kvalheim
2011). Selectivity ratios (SRs) (Rajalahti et al. 2009a, b)
were obtained as the ratio of explained to residual variance
for each FA (or lipoprotein feature) on the predictive (target)
component. By multiplying the SRs with the sign of the
corresponding loading on the predictive component, an SR
plot was constructed. This plot displays the FAs (or
lipoprotein features) according to their discriminatory
importance for the model. From the RDCV procedure,
confidence bounds can be constructed around each SR value
and used to assess the significance of each variable sepa-
rately. By using the same procedure to calculate rank sums
for two groups of subjects as in the WMW rank sum test for
unpaired measurements of two groups, we can obtain a rank
sum classification rate (RSCR) for each variable. Every
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variable is sorted from smallest to largest and given a rank
starting from one for the smallest value and increasing in
step by one until the largest one which gets a rank equal to
the number of samples. We can then calculate a summed
rank for each group that can be compared with the minimum
possible rank in each group corresponding to perfect clas-
sification. From these numbers, the RSCR can be calculated.
Subjects from one group that are located far into the other
group reduce RSCR more than subjects that are border-line.
The RSCR can be used to connect SR values to the uni-
variate WMW test statistics and to the corresponding uni-
variate classification performance.
Standard partial least squares (PLS) regression models
(Wold et al. 1984) for adults with age as y-variable were then
created for both genders based on either the FAs (supple-
mentary material 1) or the lipoprotein features (supple-
mentarymaterial 2). Performancemeasures for thesemodels
are provided in Table 1. SR plots were obtained using the
same procedure as for the PLS-DA models. These plots
display and rank the FAs and the lipoprotein features
according to their importance for predicting age in adults.
As an additional validation of the results, the above
procedure was repeated with separate modeling of the two
batches of samples. The results are presented in Table 1
above. Hierarchical clustering (HCA) with average linkage
for clustering and Euclidean distance as metric (Kaufman
and Rousseeuw 1990) was subsequently employed with SR
profiles as input to assess similarity between models based
on batch A, batch B and the combination of A and B.
3 Results and discussions
3.1 Differences in medians between children
and adults
Previous work (Freedman et al. 2004; Johnson et al. 2004;
Lin et al. 2016) has shown large gender differences in both
FA and lipoprotein patterns. Thus, males and females have
to be analyzed separately. Supplementary material 1 shows
medians of FAs, TFA and EPA/AA calculated for children
and adults of both genders. Furthermore, p-values from
Wilcoxon-Mann–Whitney (WMW) unpaired rank sum test
are shown for a comparison of medians between children
and adults for both genders. These p-values have to be
corrected for multiple testing. If we assume that the 20 FA
features constitute the same family of tests and use the
Bonferroni correction, the pWMW-values have to be less or
Table 1 Performance measures
calculated for all models. A and
B in parentheses imply samples
from subjects recruited in the
first (A) and second (B) round,
respectively
Model R2Y Q2Y % CCR p value
Girls & women (A ? B), FAs 0.63 0.48 ± 0.03 86 0.001
Boys & men (A ? B), FAs 0.65 0.57 ± 0.02 89 0.001
Women (A ? B), age = f(FAs) 0.36 0.19 ± 0.04 0.007
Men (A ? B), age = f(FAs) No validated model
Girls & women (A ? B), lipoproteins 0.36 0.24 ± 0.04 72 0.016
Boys & men (A ? B), lipoproteins 0.64 0.59 ± 0.01 88 0.001
Women (A ? B), age = f(lipoproteins) 0.32 0.22 ± 0.02 0.001
Men (A ? B), age = f(lipoproteins) 0.40 0.28 ± 0.03 0.001
Girls & women (A), FAs 0.64 0.37 ± 0.09 84 0.029
Girls & women (B), FAs 0.58 0.35 ± 0.03 80 0.029
Boys & men (A), FAs 0.67 0.49 ± 0.07 82 0.009
Boys & men (B), FAs 0.63 0.52 ± 0.24 86 0.004
Women (A), age = f(FAs) 0.37 0.16 ± 0.07 0.033
Women (B), age = f(FAs) 0.75 0.25 ± 0.05 0.002
Girls & women (A), lipoproteins 0.68 0.37 ± 0.06 90 0.034
Girls & women (B), lipoproteins 0.25 0.13 ± 0.02 69 0.064
Boys & men (A), lipoproteins 0.69 0.56 ± 0.02 90 0.008
Boys & men (B), lipoproteins 0.65 0.57 ± 0.03 89 0.005
Women (A), age = f(lipoproteins) 0.43 0.23 ± 0.09 0.001
Women (B), age = f(lipoproteins) No validated model
Men (A), age = f(lipoproteins) 0.38 0.20 ± 0.08 0.019
Men (B), age = f(lipoproteins) 0.54 0.36 ± 0.06 0.001
Calculation of Q2Y and % correct classification rate (% CCR) is based on RDCV (Westerhuis et al. 2008)
with 10 % of samples in outer loop for predictions and 100 repetitions. Mean and confidence limits
corresponding to two standard deviations are provided. The p values are calculated from randomization
tests with 1000 permutations and RDCV with 10 % of subjects in outer loop
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equal to 0.0005 to be significant for pBonferroni = 0.01. After
this correction, only EPA, DHA, EPA/AA and nervonic acid
(24:1 n-9) show significant differences in the medians of
prepubertal and adult females, while docosapentaenoci acid
(DPA) is just on the borderline of significance.
Comparison of prepubertal and adult males presents a
different picture. Only for seven FAs are the medians not
significantly different after Bonferroni correction. The
borderline is drawn between nervonic acid (significant) and
22:0 (not significant). The most significant differences are
found for DHA, DPA, 18:1 n-7, 16:1 n-7, EPA and EPA/
AA with Bonferroni corrected p-values in the range
2.8 9 10-12–6.8 9 10-9.
If we instead use false discovery rate (FDR) (Benjamini
and Hochberg 1995) for assessment of significance, then
pWMW = 0.0075 corresponds to pFDR = 0.01 and also the
medians for the FAs 22:0 and 14:0 are significantly different
between boys and men. The same kind of approach applied
for comparison of medians in girls and women adds DPA,
24:0 and linoleic acid (LA) as significantly different at
pFDR = 0.01 which corresponds to pWMW = 0.0035.
Thus, both genders experience significant increase in
concentrations of EPA, DHA and EPA/AA from prepuberty
to adulthood, but males show pronounced increase also in
many other FAs. The lower concentrations of EPA and DHA
in children compared to adults may, however, imply that
these two crucial FAs are utilized at a higher rate during
childhood with rapid development of brain and body (Rise´
et al. 2013). Overnight fasting before sampling may thus
explain why EPA and DHA are low in children´s serum. An
alternative explanation is that the children’s dietary intake is
different from the adults’, the two groups being separated
by, on the average, 30 years in age. Since children and adults
live in the same Fjord region and are influenced by the same
food culture, this explanation seems less plausible than the
biological hypothesis of attributing the difference to growth
versus maintenance of brain and body.
Supplementary material 2 shows the medians of main and
subclasses of lipoproteins and the average particle size of
VLDL, LDL and HDL for children and adults of both gen-
ders together with p-values comparing children with adults
using the WMW unpaired rank sum test. Regarding all the
24 features as belonging to one family of test, the borderline
corresponding to p = 0.01 for Bonferroni corrected p-val-
ues, is pWMW = 4.2 9 10
-4. For females, only the medians
of the subclasses of very small and small LDL particles are
significantly different between pre-puberty girls and
women. They have pBonferroni-values of 1.6 9 10
-5 and
1.5 9 10-3, respectively. The median of very small HDL
particles is just on the borderline of significance with pBon-
ferroni = 1.3 9 10
-2. For males the picture is very different.
Only the medians of small HDL particles and ApoA1 are not
significantly different at pBonferroni = 0.01.
Using the approach of FDR does not change the picture.
Thus, pFDR = 0.01 corresponds to pWMW = 0.00125 and
the changes in median for very small HDL particles unites
with small and very small LDL particles as significantly
different for prepubertal and adult females. For males,
pFDR = 0.01 corresponds to pWMW = 0.00958 and ApoA1
adds as significant for males. In summary, large changes in
lipoprotein distribution are observed for males, while only
few significant changes are revealed for females from
prepuberty to adulthood.
3.2 Changes in FA pattern during aging
PLS-DAwas used to investigate alterations of FA profiles in
males and females from prepuberty to adulthood. Strong
discriminatory models (Table 1) could be established for
both males and females using age group as dependent
variables (children = 0, adults = 1). In order to reveal
which features were responsible for the discrimination in FA
profiles between children and adults, target projection (TP)
was performed to obtain a single discriminatory component
for eachmodel. From this component selectivity ratios (SRs)
were calculated for all features and presented as SR plots as
shown in Fig. 1. Confidence limits are calculated from the
RDCV procedure and plus and minus sign indicates increase
or decrease from prepuberty to adulthood and corresponds to
positive or negative loadings on the discriminatory (target)
component. The SR plot reveals clear gender differences.
For females (Fig. 1, red color) the largest changes from
prepuberty to adulthood are observed for DHA (SR = 0.55),
EPA (SR = 0.36), and EPA/AA (SR = 0.35). Concentra-
tions of DPA (SR = 0.21), nervonic acid (SR = 0.15), LA
(SR = 0.14) and 24:0 (SR = 0.13) show small changes
between children and adults. All the other FAs have SR close
to zero and are thus unaltered in concentrations from pre-
puberty to adulthood in females. By calculating the rank sum
classification rate (RSCR). it is possible to relate the dis-
criminatory ability of individual FAs to SR. While RSCR is
77 % for the most discriminating FA, namely DHA, it is
reduced to 67 % for DPA. These observations are in line
with the results from comparison of medians from the
Bonferroni corrected WMW-tests discussed above. The
observed age-related increase in absolute DHA and EPA
concentrations complies with other investigations published
recently (Rise´ et al. 2013; Otsuka et al. 2013, 2015; Harris
et al. 2013).
For males the pattern of change in FAs are more complex
than for females. The SR plot (Fig. 1, blue color) reveals
changes also in many of the C14–C18 FAs. Thus, in addition
to similar changes as for females with increase in serum levels
of DHA (SR = 1.2), DPA (SR = 0.7), EPA (SR = 0.7) and
EPA/AA (SR = 0.5), also C14–C18 FAs increase in con-
centrations. In particular, 18:1 n-7 (SR = 0.9) and 16:1 n-9
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(SR = 0.7) increase inmales, but also some of the other C14–
C18 FAs show significant increase such as LA (SR = 0.4)
and a-linolenic acid (ALA), 18:3 n-3, (SR = 0.4). DHA,
DPA and EPA all provide RSCR larger than 82 % underlin-
ing their significant increase in concentration fromprepuberty
to adulthood in males.
We have so far only considered the changes in FA profiles
between children and adults, but the cohort of adults have a
span in age of approximately 40 years with a mean of 40.
Although both genetic factors and lifestyle with respect to
diet and level of physical activity impact on the FA profiles
of individual subjects (Aadland et al. 2013), it is worth trying
to associate features of the FA profiles to age in order to
examine if the increase in serum levels of the marine omega-
3 FAs observed between children and adults may represent a
continuous process accompanying aging.
It was not possible to obtain a validated multivariate
model for men, but for women a validated PLS model with
weak, but significant predictive ability was obtained. The
model performance measures (Table 1) reflect, as expec-
ted, that variation in age alone cannot account for the
variation in the FA profiles. The root mean square error of
prediction (RMSEP) of 10 ± 0.3 years confirmed this. The
SR plot (Fig. 2) is dominated by large increase in the
marine omega-3 FAs: DPA (SR = 2.9), EPA (SR = 2.2),
DHA (SR = 1.4) and the ratio EPA/AA (SR = 1.5). These
are the same FAs that dominated the model comparing
children with adults except that DPA seems to increase
more than EPA and DHA with age in the adult female
cohort. Our conclusions complies with results from previ-
ous investigations using univariate statistics to test for age-
related changes in EPA, DHA and EPA/AA (Otsuka et al.
2013, 2015; Harris et al. 2013; Rise´ et al. 2013),
3.3 Changes in lipoprotein pattern during aging
PLS-DA with age group as dependent variables (chil-
dren = 0, adults = 1).was subsequently used to investigate
alterations of lipoprotein features in males and females
from prepuberty to adulthood. The changes in lipoprotein
pattern are much more pronounced in males than in
females (Supplementary material 2).
SR plot for both models is shown in Fig. 3 and reveals
distinct gender differences in patterns. Lipoprotein features
in females (Fig. 3, red color) seem to undergo small
changes from prepuberty to adulthood. Increase in con-
centrations of the very small (SR = 0.52) and small
(SR = 0.33) LDL particles and very small HDL
(SR = 0.45) particles are the most striking features fol-
lowed by increase in total concentration of cholesterol
(SR = 0.30) and LDL particles (SR = 0.26). RSCR is
larger or equal to 72 % for all these features. This shows a
shift towards a more atherogenic pattern in females, but the
change is small, in line with the conclusions from the
univariate tests in Sect. 3.1. As for the FA profiles, males
(Fig. 3, blue color) show a more complex pattern of change
in lipoprotein features from prepuberty to adulthood than
females, and, unfortunately, to a more atherogenic pattern.
Thus, large increase is observed for serum concentrations
of TG (SR = 1.3), ApoB (SR = 0.8), VLDL (SR = 1.9),
and LDL (SR = 1.0), and their subclasses VLDL-VL
(SR = 1.2), VLDL-L (SR = 2.5), VLDL-M (SR = 1.2),
LDL-S (SR = 1.5) and LDL-VS (SR = 1.4). Furthermore,
total concentrations of HDL (SR = -0.8) together with the
subclasses HDL-VL (SR = -0.4), HDL-L (SR = -0.8),
and HDL-M (SR = -1.2), and thus the average size of
HDL particles, HDL-Size (SR = -1.08), are reduced from
Fig. 1 SR plot displaying
changes in fatty acid patterns
from prepuberty to adulthood
for females (red), and, males
(blue). Confidence limits
correspond to two standard
deviations (Color figure online)
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childhood to adulthood, while the suspected atherogenic
subclass (Freedman et al. 1998; Lin et al. 2016) HDL-VS
(SR = 0.6) increases. RSCR is larger or equal to 82 % for
both the atherogenic subclasses LDL-S and LDL-VS and
their associate ApoB. This pattern implies a decline in
cardiovascular (CV) health for males from prepuberty to
adulthood that was only weakly present in females. These
changes point to increased CVD risk for males compared to
females (Furusyo et al. 2013 and refs. therein). These
observations comply with the increase in C14–C18 FAs for
males observed in Fig. 1 since we have found significant
associations between C14 and C18 FAs and these
lipoprotein features in a previous investigation (Lin et al.
2016).
Multivariate PLS models were subsequently constructed
for associating lipoprotein profiles to age for the adult
cohort with performance characteristics as displayed in
Table 1. RMSEP was 10.1 ± 0.2 years for women and
9.6 ± 0.2 years for men showing that other factors than
age have large impact on the lipoprotein profile, The SR
plot for women (Fig. 4, red color) reveals increase in
concentrations of total cholesterol (SR = 6.9), ApoB
(SR = 2.3), LDL (SR = 3.9), the subclass of small VLDL
(SR = 1.0) and all subclasses of LDL particles, i.e. large
(SR = 3.3), medium (SR = 3.1), small (SR = 1.0) and
very small (SR = 1.0) LDL particles with age. Thus,
although the change from prepuberty to adulthood is
smaller for females than for males there is a progressive
development towards a more atherogenic lipoprotein pat-
tern during aging also in the adult female cohort.
The SR plot for men (Fig. 4, blue color) with changes in
lipoprotein pattern accompanying increased age is different
Fig. 2 SR plot displaying
changes in fatty acid pattern
during aging for women.
Confidence limits correspond to
two standard deviations
Fig. 3 SR plot displaying
changes in lipoprotein patterns
from prepuberty to adulthood
for females (red), and, males
(blue). Confidence limits
correspond to two standard
deviations (Color figure online)
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from women. Although many of the dominating features
are the same, such as increase in concentrations of total
cholesterol (SR = 1.0), ApoB (SR = 0.4) and LDL
(SR = 0.7) and the subclasses of small VLDL (SR = 0.8)
and, large (SR = 1.4) and medium (SR = 0.6) LDL par-
ticles, the relative age-related changes are smaller as
reflected in the smaller SR values, but from higher con-
centration levels after puberty compared to women. There
are also opposing features such as increase in concentra-
tions of ‘‘healthy’’ lipoproteins such as HDL (SR = 0.6)
and ApoA1 (SR = 0.9) and almost no changes in con-
centrations of the atherogenic small (SR = 0.1) and very
small (SR = 0.1) LDL particles. These observations
underline that other factors, than just age, must be impor-
tant to explain the changes in lipoprotein pattern in adult
males.
3.4 Validation of results using HCA of models
from separate batches
In order to validate results, separate models were calcu-
lated for the two batches (Table 1). For FAs, models with
almost the same performance were obtained for each batch
separately as for the combined batches. For lipoproteins,
the low number of women in batch B, only 24, caused
problems both for the models comparing patterns in girls
and women and for predicting age in adults. This is
expected since the lipoprotein patterns in girls and women
are relatively similar as shown by the rather ow Q2Y and
%CCR also for the model of the combined batches. Fur-
thermore, predicting age for women from only 24 subjects,
spanning a range of 20–60 years and with samples being
spent in outer and inner loop for validation, leaves too few
subjects for modelling and no validated model is obtained.
As a last step in the validation, we used hierarchical
cluster analysis (HCA) to compare models on the basis of
their SR pattern (Fig. 5). FA models are more similar than
lipoprotein models, and, for the discriminatory models,
males and female models group in separate clusters. For
change of lipoprotein pattern with age, no FA model was
possible for men, but for females, the dendrogram shows
that the SR patterns are quite similar. For lipoproteins,
batch A breaks the pattern by being different from batch B
and the models combining batch A and B for males. PCA
with SR profiles as input showed that batch A had larger
increase in small and very small LDL particles and apoB
than batch B from prepuberty boys to men and that increase
in cholesterol had a much larger impact in the age model
for men from batch A than batch B.
4 Concluding remarks
We have shown that, for both genders, the absolute
concentrations of serum EPA and DHA increase from
prepuberty to adulthood. For women the process contin-
ues during aging, but we were not able to validate this for
men. For males most C16–C18 FAs also increase from
prepuberty to adulthood, but this was not observed for
females.
The lipoprotein pattern changes to a more atherogenic
pattern for males during the transformation from prepu-
berty to adulthood, while changes are much less pro-
nounced for females. However, females show increase in
atherogenic small and very small LDL particles. During the
aging process in adults, the relative changes in lipoprotein
pattern with impact on CV health appear more pronounced
in woman than men, but women start from a much more
Fig. 4 SR plot displaying
changes in lipoprotein pattern
during aging for women (red),
and, men (blue). Confidence
limits correspond to two
standard deviations (Color
figure online)
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favorable pattern after puberty than men. Thus, the gender
differences in CV health narrow with age, but the mortality
rate from coronary heart disease (CHD) among women
never exceeds that of men (Freedman et al. 2004 and ref-
erences therein).
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